Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
70.16
+0.05 (0.07%)
At close: Dec 26, 2025, 4:00 PM EST
70.25
+0.09 (0.13%)
After-hours: Dec 26, 2025, 7:43 PM EST

Arrowhead Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 2016 - 2020
9,5284,7692,4082,8803,4986,509
Upgrade
Market Cap Growth
220.12%98.03%-16.40%-17.67%-46.25%47.77%
Upgrade
Enterprise Value
9,3454,5812,4362,7993,1836,017
Upgrade
Last Close Price
70.1634.4919.3726.8733.0562.43
Upgrade
PS Ratio
11.315.75678.1211.9614.3847.07
Upgrade
PB Ratio
20.439.4712.6010.038.3615.92
Upgrade
P/TBV Ratio
20.7510.3913.6111.039.0516.47
Upgrade
P/FCF Ratio
60.7330.40---44.06
Upgrade
P/OCF Ratio
53.0726.56---37.99
Upgrade
EV/Sales Ratio
11.275.52686.0211.6313.0943.51
Upgrade
EV/EBITDA Ratio
76.4237.47----
Upgrade
EV/EBIT Ratio
95.0246.58----
Upgrade
EV/FCF Ratio
59.5629.20---40.72
Upgrade
Debt / Equity Ratio
1.461.464.461.340.200.06
Upgrade
Debt / EBITDA Ratio
5.295.29----
Upgrade
Debt / FCF Ratio
4.684.68---0.17
Upgrade
Asset Turnover
0.660.660.000.330.350.22
Upgrade
Quick Ratio
4.734.736.573.752.672.58
Upgrade
Current Ratio
4.864.866.743.952.922.63
Upgrade
Return on Equity (ROE)
8.67%8.67%-254.98%-59.33%-42.68%-32.36%
Upgrade
Return on Assets (ROA)
4.87%4.87%-39.43%-17.58%-15.91%-15.11%
Upgrade
Return on Capital (ROIC)
5.39%5.39%-43.84%-21.89%-23.88%-20.31%
Upgrade
Return on Capital Employed (ROCE)
8.30%8.30%-58.00%-31.10%-32.30%-26.40%
Upgrade
Earnings Yield
-0.02%-0.03%-24.90%-7.13%-5.03%-2.16%
Upgrade
FCF Yield
1.65%3.29%-25.10%-11.48%-5.40%2.27%
Upgrade
Buyback Yield / Dilution
-11.67%-11.67%-12.21%-1.26%-1.62%-3.00%
Upgrade
Updated Nov 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q